Fresenius Medical Care AG (FMS)
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
- Ticker
- FMS
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- 52-week range
- $20.02 - $26.42
Valuation
- Share price
- $23.40 (close of Nov 6, 2026)
- P/E (TTM)
- 13.99x
- Price to book
- 0.80x
- Price to free cash flow
- 4.34x
Price performance
| Period | Change |
|---|---|
| 1 day | -1.10% |
| 5 days | +4.14% |
| 1 month | +4.37% |
| 3 months | -2.90% |
| 6 months | +11.38% |
| Year to date | -1.76% |
| 1 year | -3.70% |
| 3 years | +37.97% |
| 5 years | -34.07% |
| 10 years | -42.53% |
| All time | +121.54% |
Short interest
- As of
- Oct 15, 2026
- Short % of float
- 1.02%
- Shares short
- 3.96M
- Days to cover
- 3.51
- Change since prior report
- +39.71%
- Source
- FINRA consolidated short interest
Profitability and growth
- Return on equity
- 6.85%
- Return on invested capital
- 6.01%
- Return on assets
- 3.16%
- Return on capital employed
- 7.38%
- Gross margin
- 25.62%
- Net margin
- 4.98%
- EBITDA margin
- 16.76%
- Revenue growth
- 1.51%
- Net income growth
- 81.88%
- Free cash flow growth
- 12.36%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 23.03%
- Current ratio
- 0.99x
- Net debt to EBITDA
- 2.71x
Latest reported year
- Period end
- Dec 31, 2025
- Fiscal year
- 2025
- Shares outstanding
- 582.38M
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|---|---|---|---|
| 2025-12-31 | 25.62% | 4.98% | 6.85% | 6.01% |
| 2024-12-31 | 24.60% | 2.78% | 3.41% | 4.02% |
| 2023-12-31 | 25.32% | 2.57% | 3.37% | 3.98% |
| 2022-12-31 | 27.38% | 3.47% | 4.36% | 4.14% |
| 2021-12-31 | 28.82% | 5.50% | 6.93% | 6.65% |
| 2020-12-31 | 31.01% | 6.52% | 9.44% | 8.92% |
| 2019-12-31 | 30.87% | 6.86% | 9.07% | 6.95% |
| 2018-12-31 | 31.15% | 11.98% | 15.36% | 12.47% |
| 2017-12-31 | 33.84% | 7.20% | 11.82% | 10.51% |
| 2016-12-31 | 33.89% | 6.90% | 10.35% | 9.66% |
Investor relations
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|---|---|
| 2026-11-03 | Sep 2026 | - |
| 2026-08-03 | Jun 2026 | - |
| 2026-05-05 | Mar 2026 | - |
| 2026-02-24 | Dec 2025 | - |
| 2025-11-04 | Sep 2025 | - |
| 2025-08-05 | Jun 2025 | - |
| 2025-05-06 | Mar 2025 | - |
| 2025-02-25 | Dec 2024 | - |
Filings and sources
- Company website
- freseniusmedicalcare.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
HCA Healthcare, Inc. (HCA) · DaVita Inc. (DVA) · Universal Health Services Inc (UHS) · Thermo Fisher Scientific Inc. (TMO) · Danaher Corp (DHR) · Natera, Inc. (NTRA) · Agilent Technologies, Inc. (A) · IQVIA Holdings Inc. (IQV)
Understanding these figures
Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades